Literature DB >> 17483327

Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior.

Manjari Dimri1, Mayumi Naramura, Lei Duan, Jing Chen, Cesar Ortega-Cava, Gengsheng Chen, Rasna Goswami, Norvin Fernandes, Qingshen Gao, Goberdhan P Dimri, Vimla Band, Hamid Band.   

Abstract

Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is overexpressed in as many as 60% cases of breast and other cancers. EGFR overexpression is a characteristic of highly aggressive molecular subtypes of breast cancer with basal-like and BRCA1 mutant phenotypes distinct from ErbB2-overexpressing breast cancers. Yet, EGFR is substantially weaker compared with ErbB2 in promoting the oncogenic transformation of nontumorigenic human mammary epithelial cells (human MEC), suggesting a role for cooperating oncogenes. Here, we have modeled the co-overexpression of EGFR and a biologically and clinically relevant potential modifier c-Src in two distinct immortal but nontumorigenic human MECs. Using a combination of morphologic analysis and confocal imaging of polarity markers in three-dimensional Matrigel culture together with functional analyses of early oncogenic traits, we show for the first time that EGFR and c-Src co-overexpression but not EGFR or c-Src overexpression alone unleashes an oncogenic signaling program that leads to hyperproliferation and loss of polarity in three-dimensional acinar cultures, marked enhancement of migratory and invasive behavior, and anchorage-independent growth. Our results establish that EGFR overexpression in an appropriate context (modeled here using c-Src overexpression) can initiate oncogenic transformation of nontumorigenic human MECs and provide a suitable in vitro model to interrogate human breast cancer-relevant oncogenic signaling pathways initiated by overexpressed EGFR and to identify modifiers of EGFR-mediated breast oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483327     DOI: 10.1158/0008-5472.CAN-06-2580

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

2.  Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture.

Authors:  Lei Duan; Gengsheng Chen; Sumeet Virmani; GuoGuang Ying; Srikumar M Raja; Byung Min Chung; Mark A Rainey; Manjari Dimri; Cesar F Ortega-Cava; Xiangshan Zhao; Robert J Clubb; Chun Tu; Alagarsamy L Reddi; Mayumi Naramura; Vimla Band; Hamid Band
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

3.  βTrCP regulates BMI1 protein turnover via ubiquitination and degradation.

Authors:  Anagh A Sahasrabuddhe; Manjari Dimri; Prashant V Bommi; Goberdhan P Dimri
Journal:  Cell Cycle       Date:  2011-04-15       Impact factor: 4.534

Review 4.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts.

Authors:  Manjari Dimri; Jeremy D Carroll; Joon-Ho Cho; Goberdhan P Dimri
Journal:  Cell Cycle       Date:  2013-09-24       Impact factor: 4.534

6.  Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.

Authors:  Kelly L Mueller; Lauren A Hunter; Stephen P Ethier; Julie L Boerner
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.

Authors:  Manjari Dimri; Prashant V Bommi; Anagh A Sahasrabuddhe; Janardan D Khandekar; Goberdhan P Dimri
Journal:  Carcinogenesis       Date:  2009-12-07       Impact factor: 4.944

8.  EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK.

Authors:  Kelly L Mueller; Katelyn Powell; Julie M Madden; Scott T Eblen; Julie L Boerner
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

9.  Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.

Authors:  Byung Min Chung; Srikumar M Raja; Robert J Clubb; Chun Tu; Manju George; Vimla Band; Hamid Band
Journal:  BMC Cell Biol       Date:  2009-11-30       Impact factor: 4.241

10.  The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants.

Authors:  B M Chung; M Dimri; M George; A L Reddi; G Chen; V Band; H Band
Journal:  Oncogene       Date:  2009-03-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.